Radiation Oncology/NHL/Cutaneous

From Wikibooks, open books for an open world
< Radiation Oncology‎ | NHL
Jump to: navigation, search

Front Page: Radiation Oncology | RTOG Trials | Randomized Trials

Non-Hodgkin lymphoma: Main Page | Randomized
Overview: Overview | Follicular | Diffuse large B-cell | MALT | Nodal marginal zone | Mantle cell | CLL/SLL | Lymphoblastic | Burkitt | NK/T cell | Anaplastic large cell | Primary CNS Lymphoma
Treatment: Aggressive | Specific sites | Radioimmunotherapy


Cutaneous Lymphoma



  • WHO; 2008 PMID 15692063 -- "WHO-EORTC classification for cutaneous lymphomas." (Willemze R, Blood. 2005 May 15;105(10):3768-85.)
    • Classification system for primary cutaneous lymphomas


Histology Frequency 5-year DSS Clinical Course
T-cell cutaneous lymphomas
Mycosis fungoides 44% 88% Indolent
Variants of MF <5% 80-100% Indolent
Sezary syndrome 3% 24% Aggressive
Primary cutaneous anaplastic large cell lymphoma (CD30+) 8% 95% Indolent
Lymphomatoid papulosis (CD30+) 12% 100% Indolent
Subcutaneous panniculitis-like T-cell lymphoma 1% 82% Indolent
Extranodal NK/T-cell lymphoma, nasal type <1% -- Aggressive
Primary cutaneous T-cell lymphoma, unspecified 2% 16% Aggressive
B-cell cutaneous lymphomas
Primary cutaneous marginal zone B-cell lymphoma 7% 99% Indolent
Primary cutaneous follicle center lymphoma 11% 95% Indolent
Primary cutaneous diffuse large B-cell lymphoma, leg type 4% 55% Intermediate
Primary cutaneous diffuse large B-cell lymphoma, other <1% 50% Intermediate